Skip to content
Disclosery

PFM Health Sciences, LP

Follow

13F filer, CIK 1442756, SAN FRANCISCO, CA

PFM Health Sciences, LP reported $1,174,613,562 across 57 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 54.46% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-25-005245

Period
2025-06-30
Reported value
$1.17B
Holdings
57
Top 10 weight
54.46%
New
18
Sold out
27

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TEVAnew+1,238,846$20.8M
NTRAnew+101,250$17.1M
CORnew+53,287$16M
MASInew+94,451$15.9M
AKROnew+266,167$14.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VRTXexited-126,989-$61.6M
ABBVreduced-290,959-$54M
ELVexited-88,222-$38.4M
ARGXreduced-61,762-$34M
UHSexited-155,520-$29.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001085146-25-005245, largest first. % of portfolio is the value over $1,154,335,512, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 298,643 shares; 2024Q4: 298,643 shares; 2025Q1: 273,778 shares; 2025Q2: 268,023 shares 268,023$209M18.1%-5,755Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 589,409 shares; 2024Q4: 491,334 shares; 2025Q1: 491,334 shares; 2025Q2: 499,243 shares 499,243$87.9M7.61%+7,909Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 97,498 shares; 2024Q4: 97,498 shares; 2025Q1: 97,498 shares; 2025Q2: 72,313 shares 72,313$53M4.59%-25,185Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 467,427 shares; 2024Q4: 467,427 shares; 2025Q1: 556,545 shares; 2025Q2: 483,105 shares 483,105$50.4M4.37%-73,440Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 137,327 shares; 2024Q4: 93,073 shares; 2025Q1: 93,073 shares; 2025Q2: 88,967 shares 88,967$48.3M4.19%-4,106Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 166,261 shares; 2024Q4: 166,261 shares; 2025Q1: 166,261 shares; 2025Q2: 166,261 shares 166,261$42.7M3.7%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 90,766 shares; 2024Q4: 52,392 shares; 2025Q1: 186,916 shares; 2025Q2: 221,754 shares 221,754$38.3M3.32%+34,838Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 307,503 shares; 2025Q1: 595,206 shares; 2025Q2: 407,202 shares 407,202$34.1M2.96%-188,004Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 312,305 shares; 2025Q2: 479,005 shares 479,005$33M2.86%+166,700Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,685,727 shares; 2025Q2: 1,664,727 shares 1,664,727$32M2.77%-21,000Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 125,515 shares; 2024Q4: 125,515 shares; 2025Q1: 112,475 shares; 2025Q2: 161,413 shares 161,413$31.9M2.76%+48,938Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 390,863 shares; 2024Q4: 594,172 shares; 2025Q1: 379,954 shares; 2025Q2: 392,503 shares 392,503$30.7M2.66%+12,549Timeline
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 124,840 shares; 2024Q4: 69,441 shares; 2025Q1: 77,464 shares; 2025Q2: 72,290 shares 72,290$27.7M2.4%-5,174Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 101,954 shares; 2024Q4: 83,037 shares; 2025Q1: 63,238 shares; 2025Q2: 109,511 shares 109,511$26.8M2.32%+46,273Timeline
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 70,088 shares; 2024Q4: 70,088 shares; 2025Q1: 70,088 shares; 2025Q2: 85,739 shares 85,739$25.5M2.21%+15,651Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 87,145 shares; 2025Q2: 72,220 shares 72,220$23.6M2.04%-14,925Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 290,242 shares; 2025Q1: 908,135 shares; 2025Q2: 521,793 shares 521,793$22.5M1.95%-386,342Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 397,024 shares; 2025Q1: not reported; 2025Q2: 1,238,846 shares 1,238,846$20.8M1.8%newTimeline
INDIVIOR PLCINDIVIOR PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,159,833 shares; 2025Q2: 1,355,931 shares 1,355,931$20M1.73%+196,098
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 101,250 shares 101,250$17.1M1.48%newTimeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 53,287 shares 53,287$16M1.38%newTimeline
MASIMASIMO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 94,451 shares 94,451$15.9M1.38%newTimeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 860,821 shares; 2024Q4: 860,821 shares; 2025Q1: 860,821 shares; 2025Q2: 735,033 shares 735,033$15.8M1.37%-125,788Timeline
WATWATERS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 51,063 shares; 2024Q4: 59,053 shares; 2025Q1: 51,858 shares; 2025Q2: 43,089 shares 43,089$15M1.3%-8,769Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 266,167 shares 266,167$14.2M1.23%newTimeline
HOLXHOLOGIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 211,986 shares 211,986$13.8M1.2%newTimeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 88,157 shares 88,157$13.6M1.18%newTimeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 923,375 shares 923,375$12.9M1.12%newTimeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 116,532 shares; 2024Q4: 128,637 shares; 2025Q1: 41,038 shares; 2025Q2: 88,181 shares 88,181$12.8M1.11%+47,143Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 75,588 shares; 2024Q4: 75,588 shares; 2025Q1: 35,904 shares; 2025Q2: 34,623 shares 34,623$10.8M0.94%-1,281Timeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 12,427 shares; 2025Q1: not reported; 2025Q2: 17,129 shares 17,129$10.6M0.92%newTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 52,500 shares; 2025Q1: not reported; 2025Q2: 36,391 shares 36,391$10.5M0.91%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 178,319 shares 178,319$9.8M0.85%newTimeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 183,882 shares 183,882$9.67M0.84%new
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 80,416 shares 80,416$7.61M0.66%new
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 403,861 shares; 2024Q4: 331,741 shares; 2025Q1: 331,741 shares; 2025Q2: 40,782 shares 40,782$7.57M0.66%-290,959Timeline
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 42,840 shares; 2025Q1: 46,453 shares; 2025Q2: 48,444 shares 48,444$6.21M0.54%+1,991
NEONEOGENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 585,381 shares; 2025Q2: 770,038 shares 770,038$5.63M0.49%+184,657Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 451,267 shares; 2024Q4: 451,267 shares; 2025Q1: 451,267 shares; 2025Q2: 1,779,259 shares 1,779,259$4.98M0.43%+1,327,992Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 834,135 shares; 2025Q2: 732,256 shares 732,256$4.69M0.41%-101,879Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 269,158 shares; 2024Q4: 371,766 shares; 2025Q1: 570,546 shares; 2025Q2: 344,972 shares 344,972$4.53M0.39%-225,574Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 86,832 shares; 2024Q4: 63,699 shares; 2025Q1: 68,999 shares; 2025Q2: 7,237 shares 7,237$3.99M0.35%-61,762Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 183,092 shares; 2024Q4: 119,509 shares; 2025Q1: 160,866 shares; 2025Q2: 84,713 shares 84,713$3.56M0.31%-76,153Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 135,546 shares; 2024Q4: 135,546 shares; 2025Q1: 439,283 shares; 2025Q2: 244,261 shares 244,261$3.49M0.3%-195,022Timeline
IOBTQIO BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,341,107 shares; 2024Q4: 2,341,107 shares; 2025Q1: 2,341,107 shares; 2025Q2: 1,972,073 shares 1,972,073$2.74M0.24%-369,034Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 121,628 shares; 2024Q4: 283,158 shares; 2025Q1: 599,967 shares; 2025Q2: 174,331 shares 174,331$2.43M0.21%-425,636Timeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 434,134 shares 434,134$1.94M0.17%newTimeline
CRBUCARIBOU BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,306,671 shares; 2024Q4: 3,876,462 shares; 2025Q1: 2,506,435 shares; 2025Q2: 1,358,831 shares 1,358,831$1.71M0.15%-1,147,604Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 30,799 shares 30,799$1.63M0.14%newTimeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 166,803 shares; 2025Q1: not reported; 2025Q2: 12,821 shares 12,821$1.61M0.14%newTimeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,876,911 shares; 2024Q4: 4,390,427 shares; 2025Q1: 3,489,559 shares; 2025Q2: 1,072,224 shares 1,072,224$1.36M0.12%-2,417,335Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 40,400 shares; 2025Q2: 56,594 shares 56,594$1.17M0.1%+16,194Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,729 shares 37,729$1000K0.09%newTimeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 649,006 shares; 2024Q4: 649,006 shares; 2025Q1: 649,006 shares; 2025Q2: 90,000 shares 90,000$686K0.06%-559,006Timeline
HOWLWEREWOLF THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,398,747 shares; 2024Q4: 2,905,465 shares; 2025Q1: 2,506,520 shares; 2025Q2: 401,110 shares 401,110$437K0.04%-2,105,410Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
UNHUNITEDHEALTH GROUP INC COMput65,000$20.3Mnew

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
ASCENDIS PHARMA A/SASCENDIS PHARMA A/S Convertible bondprincipal23,000,000$28.8M0

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
XLVSELECT SECTOR SPDR TR429,700$62.7Mcall
VRTXVERTEX PHARMACEUTICALS INC126,989$61.6Mshares
ELVELEVANCE HEALTH INC FORMERLY88,222$38.4Mshares
UHSUNIVERSAL HLTH SVCS INC155,520$29.2Mshares
BDXBECTON DICKINSON & CO91,571$21Mshares
IQVIQVIA HLDGS INC111,854$19.7Mshares
SNDXSYNDAX PHARMACEUTICALS INC926,424$11.4Mshares
AZNASTRAZENECA PLC-SPONS ADR150,200$11Mshares
TMOTHERMO FISHER SCIENTIFIC INC21,897$10.9Mshares
XRTSPDR SERIES TRUST157,200$10.9Mcall
SAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INC10,000,000$9.31Mprincipal
CNCCENTENE CORP DEL135,398$8.22Mshares
BHVNBIOHAVEN LTD197,307$4.74Mshares
PMVPPMV PHARMACEUTICALS INC3,301,942$3.6Mshares
SRPTSAREPTA THERAPEUTICS INC50,809$3.24Mshares
XENEXENON PHARMACEUTICALS INC92,236$3.09Mshares
XRTSPDR SERIES TRUST36,471$2.52Mshares
CAPRCAPRICOR THERAPEUTICS INC140,681$1.34Mshares
MGXMETAGENOMI THERAPEUTICS INC885,803$1.2Mshares
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC26,437$1.17Mshares
KROSKEROS THERAPEUTICS INC104,323$1.06Mshares
ACLXARCELLX INC15,488$1.02Mshares
VERVE THERAPEUTICS INCVERVE THERAPEUTICS INC155,495$711Kshares
CELCCELCUITY INC53,349$539Kshares
IOVAIOVANCE BIOTHERAPEUTICS INC132,152$440Kshares
TURNSTONE BIOLOGICS CORPTURNSTONE BIOLOGICS CORP932,348$382Kshares
BOLDBOUNDLESS BIO INC240,513$363Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-25-005245 base2025-08-14acceptance time not in the bulk data set